BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 17549625)

  • 1. Is BRCA2 c.9079 G>A a predisposing variant for early onset breast cancer?
    Hammet F; George J; Tesoriero AA; Jenkins MA; Schroen C; Smith L; Grabosch-Meehan A; Dite G; McCredie MR; Giles GG; Tavtigian SV; Hopper JL; Southey MC
    Breast Cancer Res Treat; 2008 May; 109(1):177-9. PubMed ID: 17549625
    [No Abstract]   [Full Text] [Related]  

  • 2. Should a BRCA2 stop codon human variant, usually considered a polymorphism, be classified as a predisposing mutation?
    D'Argenio V; Esposito MV; Gilder JA; Frisso G; Salvatore F
    Cancer; 2014 May; 120(10):1594-5. PubMed ID: 24500773
    [No Abstract]   [Full Text] [Related]  

  • 3. Central European BRCA2 mutation carriers: birth cohort status correlates with onset of breast cancer.
    Tea MK; Kroiss R; Muhr D; Fuerhauser-Rappaport C; Oefner P; Wagner TM; Singer CF
    Maturitas; 2014 Jan; 77(1):68-72. PubMed ID: 24156927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of breast cancer susceptibility genes BRCA1 and BRCA2 in Thai familial and isolated early-onset breast and ovarian cancer.
    Patmasiriwat P; Bhothisuwan K; Sinilnikova OM; Chopin S; Methakijvaroon S; Badzioch M; Padungsutt P; Vattanaviboon P; Vattanasapt V; Szabo C; Saunders GF; Goldgar D; Lenoir GM
    Hum Mutat; 2002 Sep; 20(3):230. PubMed ID: 12203997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The contribution of founder mutations to early-onset breast cancer in French-Canadian women.
    Ghadirian P; Robidoux A; Zhang P; Royer R; Akbari M; Zhang S; Fafard E; Costa M; Martin G; Potvin C; Patocskai E; Larouche N; Younan R; Nassif E; Giroux S; Narod SA; Rousseau F; Foulkes WD
    Clin Genet; 2009 Nov; 76(5):421-6. PubMed ID: 19863560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The BRCA2 372 HH genotype is associated with risk of breast cancer in Australian women under age 60 years.
    Spurdle AB; Hopper JL; Chen X; Dite GS; Cui J; McCredie MR; Giles GG; Ellis-Steinborner S; Venter DJ; Newman B; Southey MC; Chenevix-Trench G
    Cancer Epidemiol Biomarkers Prev; 2002 Apr; 11(4):413-6. PubMed ID: 11927503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. No Evidence for the Pathogenicity of the BRCA2 c.6937 + 594T>G Deep Intronic Variant: A Case-Control Analysis.
    Dutil J; Godoy L; Rivera-Lugo R; Arroyo N; Albino E; Negrón L; Monteiro AN; Matta JL; Echenique M
    Genet Test Mol Biomarkers; 2018 Feb; 22(2):85-89. PubMed ID: 29356578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Twenty-three novel BRCA1 and BRCA2 sequence alterations in breast and/or ovarian cancer families in Southern Germany.
    Meyer P; Voigtlaender T; Bartram CR; Klaes R
    Hum Mutat; 2003 Sep; 22(3):259. PubMed ID: 12938098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel BRCA2 in frame deletion in a Tunisian woman with early onset sporadic breast cancer.
    Hadiji-Abbes N; Trifa F; Choura M; Khabir A; Sellami-Boudawara T; Frikha M; Daoud J; Mokdad-Gargouri R
    Pathol Biol (Paris); 2015 Sep; 63(4-5):185-9. PubMed ID: 26320393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. About the c.156_157insAlu BRCA2 breast cancer predisposing mutation.
    Teugels E; De Grève J
    Breast Cancer Res Treat; 2009 Aug; 116(3):621-2. PubMed ID: 18807268
    [No Abstract]   [Full Text] [Related]  

  • 11. CHEK2*1100delC genotyping for clinical assessment of breast cancer risk: meta-analyses of 26,000 patient cases and 27,000 controls.
    Weischer M; Bojesen SE; Ellervik C; Tybjaerg-Hansen A; Nordestgaard BG
    J Clin Oncol; 2008 Feb; 26(4):542-8. PubMed ID: 18172190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutational analysis of the BRCA2 gene in breast carcinoma patients of Kashmiri descent.
    Ayub SG; Rasool S; Ayub T; Khan SN; Wani KA; Andrabi KI
    Mol Med Rep; 2014 Feb; 9(2):749-53. PubMed ID: 24337145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BRCA1/2 germline mutations and their clinical importance in Turkish breast cancer patients.
    Cecener G; Egeli U; Tunca B; Erturk E; Ak S; Gokgoz S; Tasdelen I; Tezcan G; Demirdogen E; Bayram N; Avci N; Evrensel T
    Cancer Invest; 2014 Oct; 32(8):375-87. PubMed ID: 24884828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between polymorphisms of the BRCA2 gene and clinical parameters in breast cancer.
    Krupa R; Sliwinski T; Morawiec Z; Pawlowska E; Zadrozny M; Blasiak J
    Exp Oncol; 2009 Dec; 31(4):250-1. PubMed ID: 20010525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A common variant in BRCA2 is associated with both breast cancer risk and prenatal viability.
    Healey CS; Dunning AM; Teare MD; Chase D; Parker L; Burn J; Chang-Claude J; Mannermaa A; Kataja V; Huntsman DG; Pharoah PD; Luben RN; Easton DF; Ponder BA
    Nat Genet; 2000 Nov; 26(3):362-4. PubMed ID: 11062481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haplotype analysis of the BRCA2 9254delATCAT recurrent mutation in breast/ovarian cancer families from Spain.
    Campos B; Díez O; Odefrey F; Domènech M; Moncoutier V; Martínez-Ferrandis JI; Osorio A; Balmaña J; Barroso A; Armengod ME; Benítez J; Alonso C; Stoppa-Lyonnet D; Goldgar D; Baiget M
    Hum Mutat; 2003 Apr; 21(4):452. PubMed ID: 12655574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical management of BRCA1 and BRCA2 mutation carriers.
    Domchek SM; Armstrong K; Weber BL
    Nat Clin Pract Oncol; 2006 Jan; 3(1):2-3. PubMed ID: 16407858
    [No Abstract]   [Full Text] [Related]  

  • 18. High risk of contralateral breast carcinoma in women with hereditary/familial non-BRCA1/BRCA2 breast carcinoma.
    Shahedi K; Emanuelsson M; Wiklund F; Gronberg H
    Cancer; 2006 Mar; 106(6):1237-42. PubMed ID: 16475207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between hsa-mir-146a genotype and tumor age-of-onset in BRCA1/BRCA2-negative familial breast and ovarian cancer patients.
    Pastrello C; Polesel J; Della Puppa L; Viel A; Maestro R
    Carcinogenesis; 2010 Dec; 31(12):2124-6. PubMed ID: 20810544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of BRCA1 and BRCA2 mutations in 54 Chilean families with breast/ovarian cancer, genotype-phenotype correlations.
    Gallardo M; Silva A; Rubio L; Alvarez C; Torrealba C; Salinas M; Tapia T; Faundez P; Palma L; Riccio ME; Paredes H; Rodriguez M; Cruz A; Rousseau C; King MC; Camus M; Alvarez M; Carvallo P
    Breast Cancer Res Treat; 2006 Jan; 95(1):81-7. PubMed ID: 16261400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.